Literature DB >> 15232813

Analgesia after thoracotomy: epidural fentanyl/bupivacaine compared with intercostal nerve block plus intravenous morphine.

Mario Concha1, Jorge Dagnino, Mario Cariaga, Jorge Aguilera, Rodrigo Aparicio, Mario Guerrero.   

Abstract

OBJECTIVES: Intercostal nerve blockade plus intravenous (IV) patient-controlled analgesia (PCA) could be an easier and safer alternative to epidural analgesia for postthoracotomy pain, but information about the efficacy of this technique is scarce. The objective of this randomized study was to compare the quality of analgesia and lung function in 2 groups of patients undergoing pulmonary surgery through a posterolateral thoracotomy.
METHODS: Two groups were studied: G1 (n = 16) patients received a 5-segment intercostal block plus IV PCA morphine, and G2 (n = 15) patients received a bupivacaine and fentanyl PCA infusion through a thoracic epidural catheter. Resting and dynamic visual analog pain scale (VAS) measurements, forced vital capacity, and forced expiratory volume in 1 second were measured basally, on arrival in the recovery room, then hourly up to 4 hours and then 12, 24 and 48 hours later. Results were analyzed with a 2-way analysis of variance, chi-square, or Fisher exact test. A p value < or =0.05 was considered significant.
RESULTS: Resting and dynamic VAS scores were slightly lower in G2 patients, although only resting scores were significant. After the first hour, mean scores were below 4 in both groups. No significant difference was observed between groups in relation to respiratory parameters or side effects.
CONCLUSION: The fact that the difference in pain scores is probably not clinically significant shows that an intercostal block with bupivacaine plus IV morphine PCA is a good alternative for postthoracotomy pain management.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15232813     DOI: 10.1053/j.jvca.2004.03.013

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  7 in total

1.  Paravertebral anesthetic nerve block for pain control after peroral endoscopic myotomy.

Authors:  B Joseph Elmunzer; Briana R Lewis; Kristen F Miller; Bethany J Wolf; Lydia Zeiler; David A Gutman; Pooja Elias; Aylin Tansel; Robert A Moran; Eric D Bolin
Journal:  Tech Innov Gastrointest Endosc       Date:  2021-06-24

Review 2.  The benefits of adding epidural analgesia to general anesthesia: a metaanalysis.

Authors:  Joanne Guay
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

3.  Impact of pregabalin on early phase post-thoracotomy pain compared with epidural analgesia.

Authors:  Noriyuki Matsutani; Hitoshi Dejima; Takashi Nakayama; Yusuke Takahashi; Hirofumi Uehara; Hisae Iinuma; Toshiya Harashima; Kazuki Anraku; Masafumi Kawamura
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

4.  A randomized control trial to compare thoracic epidural with intercostal block plus intravenous morphine infusion for postoperative analgesia in patients undergoing elective thoracotomy.

Authors:  Santhosh Vilvanathan; Balaji Kuppuswamy; Raj Sahajanandan
Journal:  Ann Card Anaesth       Date:  2020 Apr-Jun

5.  Assessment of Intercostal Nerve Block Analgesia for Thoracic Surgery: A Systematic Review and Meta-analysis.

Authors:  Carlos E Guerra-Londono; Ann Privorotskiy; Crispiana Cozowicz; Rachel S Hicklen; Stavros G Memtsoudis; Edward R Mariano; Juan P Cata
Journal:  JAMA Netw Open       Date:  2021-11-01

6.  A comparative study of postoperative pulmonary complications using fast track regimen and conservative analgesic treatment: a randomized clinical trial.

Authors:  Mohsen Sokouti; Babak Abri Aghdam; Samad Eslam Jamal Golzari; Majid Moghadaszadeh
Journal:  Tanaffos       Date:  2011

7.  A randomised evaluation of intercostal block as an adjunct to epidural analgesia for post-thoracotomy pain.

Authors:  Priya Ranganathan; Asharab Tadvi; Sabita Jiwnani; George Karimundackal; C S Pramesh
Journal:  Indian J Anaesth       Date:  2020-03-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.